Clinical Trials Directory

Trials / Unknown

UnknownNCT01758666

A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Tianjin Medical University Cancer Institute and Hospital · Academic / Other
Sex
All
Age
12 Years – 60 Years
Healthy volunteers
Not accepted

Summary

At present, the most effective drugs to osteosarcoma include ADM,DDP,,HD-MTX,IFO and so on.The effective rate of single drug was about 30%, and if the chemotherapy contains HD-MTX, the survival rate can reach about 60%, so the HD-MTX is the most important component in patients of osteosarcoma. Studies have shown that, MTX efficacy and adverse reactions were associated with blood concentration level and duration, selecting the right time and dose to give CF is the critical point.

Conditions

Interventions

TypeNameDescription
DRUGMethotrexate,Calcium folinate

Timeline

Start date
2012-09-01
Primary completion
2016-11-01
Completion
2016-12-01
First posted
2013-01-01
Last updated
2015-12-22

Source: ClinicalTrials.gov record NCT01758666. Inclusion in this directory is not an endorsement.